Cargando…

Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas

INTRODUCTION: The inability of many therapeutic molecules to cross the blood–brain barrier (BBB) combined with poor penetration into tumor tissue leads to difficult challenges for treatment of brain tumors. In order to settle these hurdles, we developed a novel multifunctional targeting carrier whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Dehua, Hong, Wenyu, Yu, Miao, Li, Yanxia, Zheng, YaXin, Ying, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933639/
https://www.ncbi.nlm.nih.gov/pubmed/35313461
http://dx.doi.org/10.2147/IJN.S346948
_version_ 1784671698441732096
author Kong, Dehua
Hong, Wenyu
Yu, Miao
Li, Yanxia
Zheng, YaXin
Ying, Xue
author_facet Kong, Dehua
Hong, Wenyu
Yu, Miao
Li, Yanxia
Zheng, YaXin
Ying, Xue
author_sort Kong, Dehua
collection PubMed
description INTRODUCTION: The inability of many therapeutic molecules to cross the blood–brain barrier (BBB) combined with poor penetration into tumor tissue leads to difficult challenges for treatment of brain tumors. In order to settle these hurdles, we developed a novel multifunctional targeting carrier which enables drugs to transport across the BBB and targets brain tumor tissues. METHODS: In the multifunctional targeting liposomes, the natural compound resveratrol (RES) was incorporated into the lipid bilayer membranes of liposomes, while p-aminophenyl-α-D-manno-pyranoside (MAN) and wheat germ agglutinin (WGA) were conjugated to the liposomal surface. Epirubicin (EPI) as an anticancer drug was then loaded into liposomes. Then, liposomes were characterized by evaluation on particle size, zeta potential and apparent morphology. The epirubicin plus resveratrol liposomes modified with WGA and MAN were applied to glioma cells and BBB model in vitro and C6 glioma-bearing rats in vivo. RESULTS: The multifunctional targeting liposomes were round shaped with a smooth surface and uniform particle size. In consideration of the SRB results, the multifunctional targeting liposomes indicated a significant inhibitory effect, suggesting that MAN plus WGA generated robust drug delivery effects into the brain tumor cells. The glioma cells after administering epirubicin plus resveratrol liposomes modified with WGA and MAN displayed the most significant uptake and apoptosis conducted by flow cytometry. In the multifunctional targeting effects assay, the epirubicin plus resveratrol liposomes modified with WGA and MAN exhibited the strongest effects of crossing the BBB and then targeting brain tumor cells. In tumor-bearing rats after applying multifunctional targeting liposomes, the median survival time was evidently observed as being markedly longer than other controls. CONCLUSION: The epirubicin plus resveratrol liposomes modified with WGA and MAN exhibited strong ability to improve epirubicin and resveratrol transporting across the BBB and therapeutic effect on brain glioma, showing multifunctional targeting capability.
format Online
Article
Text
id pubmed-8933639
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-89336392022-03-20 Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas Kong, Dehua Hong, Wenyu Yu, Miao Li, Yanxia Zheng, YaXin Ying, Xue Int J Nanomedicine Original Research INTRODUCTION: The inability of many therapeutic molecules to cross the blood–brain barrier (BBB) combined with poor penetration into tumor tissue leads to difficult challenges for treatment of brain tumors. In order to settle these hurdles, we developed a novel multifunctional targeting carrier which enables drugs to transport across the BBB and targets brain tumor tissues. METHODS: In the multifunctional targeting liposomes, the natural compound resveratrol (RES) was incorporated into the lipid bilayer membranes of liposomes, while p-aminophenyl-α-D-manno-pyranoside (MAN) and wheat germ agglutinin (WGA) were conjugated to the liposomal surface. Epirubicin (EPI) as an anticancer drug was then loaded into liposomes. Then, liposomes were characterized by evaluation on particle size, zeta potential and apparent morphology. The epirubicin plus resveratrol liposomes modified with WGA and MAN were applied to glioma cells and BBB model in vitro and C6 glioma-bearing rats in vivo. RESULTS: The multifunctional targeting liposomes were round shaped with a smooth surface and uniform particle size. In consideration of the SRB results, the multifunctional targeting liposomes indicated a significant inhibitory effect, suggesting that MAN plus WGA generated robust drug delivery effects into the brain tumor cells. The glioma cells after administering epirubicin plus resveratrol liposomes modified with WGA and MAN displayed the most significant uptake and apoptosis conducted by flow cytometry. In the multifunctional targeting effects assay, the epirubicin plus resveratrol liposomes modified with WGA and MAN exhibited the strongest effects of crossing the BBB and then targeting brain tumor cells. In tumor-bearing rats after applying multifunctional targeting liposomes, the median survival time was evidently observed as being markedly longer than other controls. CONCLUSION: The epirubicin plus resveratrol liposomes modified with WGA and MAN exhibited strong ability to improve epirubicin and resveratrol transporting across the BBB and therapeutic effect on brain glioma, showing multifunctional targeting capability. Dove 2022-03-14 /pmc/articles/PMC8933639/ /pubmed/35313461 http://dx.doi.org/10.2147/IJN.S346948 Text en © 2022 Kong et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Kong, Dehua
Hong, Wenyu
Yu, Miao
Li, Yanxia
Zheng, YaXin
Ying, Xue
Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas
title Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas
title_full Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas
title_fullStr Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas
title_full_unstemmed Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas
title_short Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas
title_sort multifunctional targeting liposomes of epirubicin plus resveratrol improved therapeutic effect on brain gliomas
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933639/
https://www.ncbi.nlm.nih.gov/pubmed/35313461
http://dx.doi.org/10.2147/IJN.S346948
work_keys_str_mv AT kongdehua multifunctionaltargetingliposomesofepirubicinplusresveratrolimprovedtherapeuticeffectonbraingliomas
AT hongwenyu multifunctionaltargetingliposomesofepirubicinplusresveratrolimprovedtherapeuticeffectonbraingliomas
AT yumiao multifunctionaltargetingliposomesofepirubicinplusresveratrolimprovedtherapeuticeffectonbraingliomas
AT liyanxia multifunctionaltargetingliposomesofepirubicinplusresveratrolimprovedtherapeuticeffectonbraingliomas
AT zhengyaxin multifunctionaltargetingliposomesofepirubicinplusresveratrolimprovedtherapeuticeffectonbraingliomas
AT yingxue multifunctionaltargetingliposomesofepirubicinplusresveratrolimprovedtherapeuticeffectonbraingliomas